The previous page is sending you to http://www.prnewswire.com/news-releases/immune-pharmaceuticals-and-hadasit-file-a-joint-patent-on-the-oral-use-of-anti-eotaxin-monoclonal-antibodies-including-bertilimumab-for-the-treatment-of-gi-and-liver-diseases-300281343.html.

 If you do not want to visit that page, you can return to the previous page.